Ted Buchan & Co
BMY icon

Ted Buchan & Co’s Bristol-Myers Squibb BMY Stock Holding History

Ted Buchan & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.97M Sell
31,514
-541
-2% -$34.2K 0.65% 32
2026
Q2 		$1.85M Buy
32,055
+155
+0.5% +$8.9K 0.6% 36
2026
Q1 		$1.93M Buy
31,900
+221
+0.7% +$12.9K 0.7% 33
2025
Q4 		$1.71M Buy
31,679
+2,068
+7% +$99.5K 0.63% 36
2025
Q3 		$1.34M Buy
29,611
+2,386
+9% +$111K 0.52% 44
2025
Q2 		$1.26M Buy
27,225
+3,888
+17% +$191K 0.5% 45
2025
Q1 		$1.42M Sell
23,337
-360
-2% -$21K 0.67% 31
2024
Q4 		$1.34M Buy
23,697
+1,440
+6% +$80.5K 0.63% 33
2024
Q3 		$1.15M Buy
+22,257
New +$1.04M 0.55% 35

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Ted Buchan & Co's BMY Position: Q3 2026 in Review

Ted Buchan & Co reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q3 2026, selling an estimated $34.2K and leaving 31,514 shares worth $1.97M. The position accounts for 0.65% of the portfolio, ranked #32.

Ted Buchan & Co first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. 762 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Ted Buchan & Co held 31,514 shares of Bristol-Myers Squibb worth $1.97M as of Q3 2026.
  • Ted Buchan & Co sold 541 Bristol-Myers Squibb shares in Q3 2026, an estimated $34.2K.
  • Bristol-Myers Squibb made up 0.65% of Ted Buchan & Co's portfolio in Q3 2026, its #32 holding.
  • Ted Buchan & Co first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
  • 762 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Ted Buchan & Co's 13F filing for Q3 2026, filed 23 Oct 2026.